Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced today the commercial availability of the LAVA® Liquid Embolic System, the first and only liquid ...

Sirtex Medical introduces new LAVA Liquid Embolic System to treat peripheral vascular haemorrhage: Singapore Monday, October 30, 2023, 14:00 Hrs [IST] Sirtex, a global healthcare business, unveils ...

LAVA clinical trial underway for potential first FDA-approved liquid embolic system for a peripheral vascular indication WOBURN, Mass., April 19, 2021 /PRNewswire/ -- Sirtex Medical (Sirtex), a ...

Lava® LES is the first liquid embolic product approved by the FDA for use in the peripheral vasculature HAYWARD, Calif., April 18, 2023 /P. Tuesday, 02 January 2024 12:17 GMT.

WOBURN, Mass., April 19, 2021 /CNW/ -- Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a Bay Area-based private ...

Sirtex Medical Announces Commercial Availability Of New LAVA® Liquid Embolic System. Date. 2023-10-27 09:47:14 ...

WOBURN, Mass., Oct. 27, 2023 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced today the commercial availability of the LAVA ...